CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (ACA) is the most common subtype of non-small-cell lung cancer. About 70%–80% patients are diagnosed at an advanced stage; therefore, the survival rate is poor. It is urgent to discover accurate markers that can differentiate the late stages of lung ACA from the early...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Dayong, Dong, Siyuan, Yang, Shize, Liu, Zhenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547618/
https://www.ncbi.nlm.nih.gov/pubmed/33083148
http://dx.doi.org/10.7717/peerj.10126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547618/
https://www.ncbi.nlm.nih.gov/pubmed/33083148
http://dx.doi.org/10.7717/peerj.10126

Ejemplares similares